BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25127253)

  • 1. Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
    Mathai D; Kumar VA; Paul B; Sugumar M; John KR; Manoharan A; Kesavan LM
    Microb Drug Resist; 2015 Feb; 21(1):59-64. PubMed ID: 25127253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Hasan B; Laurell K; Rakib MM; Ahlstedt E; Hernandez J; Caceres M; Järhult JD
    Microb Drug Resist; 2016 Dec; 22(8):682-687. PubMed ID: 27007258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community.
    Ahmed SF; Ali MM; Mohamed ZK; Moussa TA; Klena JD
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():22. PubMed ID: 24934873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
    Tian SF; Chen BY; Chu YZ; Wang S
    Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.
    Ouédraogo AS; Sanou S; Kissou A; Poda A; Aberkane S; Bouzinbi N; Nacro B; Ouédraogo R; Van De Perre P; Carriere C; Decré D; Jean-Pierre H; Godreuil S
    Microb Drug Resist; 2017 Jan; 23(1):63-70. PubMed ID: 27092971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gilthead seabream (Sparus aurata) as carriers of SHV-12 and TEM-52 extended-spectrum beta-lactamases-containing Escherichia coli isolates.
    Sousa M; Torres C; Barros J; Somalo S; Igrejas G; Poeta P
    Foodborne Pathog Dis; 2011 Oct; 8(10):1139-41. PubMed ID: 21657938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.
    Woerther PL; Angebault C; Lescat M; Ruppé E; Skurnik D; Mniai AE; Clermont O; Jacquier H; Costa AD; Renard M; Bettinger RM; Epelboin L; Dupont C; Guillemot D; Rousset F; Arlet G; Denamur E; Djossou F; Andremont A
    J Infect Dis; 2010 Aug; 202(4):515-23. PubMed ID: 20617925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
    Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
    J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia.
    Ben Sallem R; Ben Slama K; Sáenz Y; Rojo-Bezares B; Estepa V; Jouini A; Gharsa H; Klibi N; Boudabous A; Torres C
    Foodborne Pathog Dis; 2012 Dec; 9(12):1137-42. PubMed ID: 23194332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V; De Barbeyrac B; Rogues AM; Arpin C; Coulange L; Andre C; M'zali F; Megraud F; Quentin C
    J Antimicrob Chemother; 2010 Jul; 65(7):1368-71. PubMed ID: 20466850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.